Curocell Company Description

Curocell Inc. develops CAR-T cell therapy for the treatment of cancer.

It focuses on the development of CD19 CAR-T for the treatment of lymphoma; and BCMA CAR-T for the treatment of multiple myeloma.

The company was incorporated in 2016 and is based in Daejeon, South Korea.

Curocell Inc.

Country	South Korea
Founded	2016
Industry	Biological Products, Except Diagnostic Substances

Contact Details

Address: 48, Yuseong-daero 1184beon-gil Daejeon, 34109 South Korea
Phone	82 4 2863 3698
Website	curocellbtx.com